Biologic therapies for psoriasis: practical experience in a U.K. tertiary referral centre

Richard B. Warren; Benjamin Brown; D. Lavery; Darren M. Ashcroft; Christopher Em Griffiths

doi:10.1111/j.1365-2133.2008.08865.x

Abstract

1 min read

In a cohort of U.K. patients with severe psoriasis, biologic therapies have proved to be a significant step forward in expanding the therapeutic armamentarium for psoriasis. Pharmacovigilance, in the form of registries, is essential to assess the long-term safety of such drugs.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2010

Adalimumab for psoriasis: practical experience in a U.K. tertiary referral centre

Richard B. Warren, Benjamin Brown, D. Lavery, Christopher Em Griffiths

Article2013

Biologic therapies in dermatology

Leena Chularojanamontri, Christopher Em Griffiths

Article2014

Baseline characteristics of patients with psoriasis enrolled in the British Association of Dermatologists' Biologic Interventions Register.

Ireny Iskandar, Richard B. Warren, Zenas Z N Yiu, Jnwn Barker, David Burden, A.D. Ormerod, Nick J. Reynolds, Catherine Smith, Christopher Em Griffiths, Darren M. Ashcroft

Article2011

Practical experience of ustekinumab in the treatment of psoriasis: experience from a multicentre, retrospective case cohort study across the U.K. and Ireland

Philip Laws, Anthony M. Downs, Richard Parslew, B. Dever, Catherine Smith, Juliet N. Barker, Bláithín Moriarty, Ruth Murphy, Brian Kirby, A. David Burden, Sandy McBride, A.V. Anstey, Sally J. O’Shea, Nicola Ralph, C. Buckley, Christopher Em Griffiths, Richard B. Warren

Editorial Material2012

Biologics for psoriasis: current evidence and future use

Christopher Em Griffiths